Peptide compounding empowers ‘charlatans,’ undermines safety

Letter of support for AB 2030: Dietary supplements for weight loss and over-the-counter diet pills

"Dear Chair Bonta and Honorable Members of the Assembly Health Committee: The Center for Science in the Public Interest strongly supports AB 2030, which would prohibit the sale of over-the-counter diet pills and weight-loss or muscle-building dietary supplements (WL/MB supplements) to minors. These products are widely available and heavily marketed to youth, often with deceptive claims, despite limited evidence of effectiveness. They are also poorly regulated and frequently contaminated with dangerous, undisclosed ingredients. National pediatric experts warn against their use, citing serious health risks including liver damage, hospitalization, and even death. This bill represents a common-sense, urgently needed step to protect young people in California." View the resource below to keep reading.

Letter of support for Food safety: unsafe additives and ingredient disclosures bill (Assemblymember Addis)

The undersigned organizations and individuals support AB 2034, a bill that will promote transparency and safety in the food system. This is essential given the longstanding failure by the U.S. Food and Drug Administration to effectively fulfill its mandate to protect consumers from unsafe and poorly tested food chemicals. AB 2034 specifically addresses two related problems caused by inadequate federal oversight of food chemicals. View the resource below to keep reading.

Raw Farm recalls cheddar cheese implicated in E. coli cases

E. coli illnesses in 3 states have been linked to Raw Farm cheddar cheese; on April 2, the company announced that it would recall implicated products.

Coalition letter for Food safety: unsafe additives and ingredient disclosures bill (Assemblymember Addis)

The undersigned organizations and individuals support AB 2034, a bill that will promote transparency and safety in the food system. This is essential given the longstanding failure by the U.S. Food and Drug Administration to effectively fulfill its mandate to protect consumers from unsafe and poorly tested food chemicals. AB 2034 specifically addresses two related problems caused by inadequate federal oversight of food chemicals. View the resource below to keep reading.

Substantial improvement in availability of corn tortillas containing folic acid, CSPI analysis finds

CSPI's letter of support for David Kessler's citizen petition

The Center for Science in the Public Interest respectfully submits the following comment in support of the Citizen Petition to “Limit the Exposure of Refined Carbohydrates used in Industrial Processing in Order to Prevent Obesity, Diabetes, and Cardiovascular Disease in Children and Adults” filed by David A. Kessler on August 12, 2025 (docket number FDA-2025-P-3071; hereinafter referred to as the “petition”). CSPI is a non-profit consumer education and advocacy organization that has worked since 1971 to improve the public’s health through better nutrition and safer food. CSPI has an extensive history of advocating for policies that aim to improve the nutritional quality and safety of the U.S. diet through food chemical safety regulatory reform, food labeling, restaurant nutrition standards, school meals and competitive foods nutrition standards, and federal dietary guidance. View the resource below to keep reading.

NY & CA lawmakers demand state government protect families’ health, pass food transparency reform

How Robert F. Kennedy, Jr.’s vaccine agenda risks a resurgence of deadly childhood plagues

Health Secretary Robert F. Kennedy Jr. is spreading doubts about the safety of vaccines and considering changes that could prompt manufacturers to flee the U.S. market.

Coverage for FDA-Approved Contraceptives: U.S. Court of Appeals for the Third Circuit amicus brief

In March 2026, CSPI’s Litigation Department took a stand for scientific integrity and public health, filing an amicus brief to challenge a Trump Administration Rule that threatens to deny tens of thousands of women access to FDA-approved contraceptives under their employer-sponsored health plans. The brief, which was filed on behalf of three former FDA officials, addresses the misleading and cherry-picked data cited by the Administration, as well as the rigorous science that goes into vetting FDA-approved contraceptives.